Marshall Wace, LLP Adma Biologics, Inc. Transaction History
Marshall Wace, LLP
- $72.2 Billion
- Q2 2024
A detailed history of Marshall Wace, LLP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 26,800 shares of ADMA stock, worth $524,476. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,800
Previous 18,597
44.11%
Holding current value
$524,476
Previous $122,000
145.08%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ADMA
# of Institutions
265Shares Held
178MCall Options Held
535KPut Options Held
21.2K-
Black Rock Inc. New York, NY18.6MShares$365 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$284 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA13.2MShares$258 Million0.03% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL8.93MShares$175 Million0.03% of portfolio
-
State Street Corp Boston, MA8.06MShares$158 Million0.0% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.84B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...